Observational Study of Blinatumomab

A Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of ARGX-113 in Patients With ITP

NCT03102593 ·Status: COMPLETED ·Phase: PHASE2

A Randomized, Double-blind, Placebo-controlled, and Multi-center Clinical Study of CM313 in the Treatment of Immune Thrombocytopenia

NCT06199089 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study to Assess the Ability of Eltrombopag to Induce Sustained Response Off Treatment in Subjects With ITP

NCT03524612 ·Status: COMPLETED ·Phase: PHASE2

A Study to Investigate Belimumab for the Treatment of Chronic Immune Thrombocytopenia.

NCT01440361 ·Status: WITHDRAWN ·Phase: PHASE2

MONICA-SC: A Study to Evaluate the Efficacy, Safety and Tolerability of Blisibimod (A-623) Administration in Subjects With ITP

NCT01609452 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3

Romiplostim N01 for Chemotherapy-induced Thrombocytopenia

NCT07063225 ·Status: RECRUITING ·Phase: PHASE2

A Study of Pirtobrutinib, Venetoclax, and Rituximab in People With Waldenström's Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)

NCT07231952 ·Status: RECRUITING ·Phase: PHASE2

Phase III Study on HMPL-523 for Treatment of ITP

NCT05029635 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment

NCT07007962 ·Status: RECRUITING ·Phase: PHASE3

Baricitinib for Steroid-resistant/Relapse Immune Thrombocytopenia

NCT05446831 ·Status: UNKNOWN ·Phase: PHASE2

An Open, Exploratory Clinical Study of CM336 in the Treatment of Immune Thrombocytopenia

NCT06799611 ·Status: RECRUITING ·Phase: PHASE2

Use of Direct Oral Anticoagulants (DOACs) in Patients With Ph-negative Myeloproliferative Neoplasms

NCT04192916 ·Status: COMPLETED

A Prospective, One-arm and Open Clinical Study of CM313 in the Treatment of Immune Thrombocytopenia

NCT05694767 ·Status: COMPLETED ·Phase: PHASE2

A Rollover Study to Provide Continued Treatment With Eltrombopag

NCT01957176 ·Status: COMPLETED ·Phase: PHASE4

Eltrombopag and Romiplostim Used Alternatively in Patients With Immune Thrombopenia (ITP): Efficacy and Safety.

NCT01618734 ·Status: COMPLETED

The Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMPL-523 in Immune Thrombocytopenia Patients

NCT03951623 ·Status: COMPLETED ·Phase: PHASE1

Study of Romiplostim for Chemotherapy Induced Thrombocytopenia

NCT02052882 ·Status: COMPLETED ·Phase: PHASE2

Study of Patients With ITP Estimating the Proportion Administering Romiplostim Correctly After Receiving Home Administration Training

NCT02085993 ·Status: COMPLETED

A Study of Eltrombopag in Patients With CMML and Thrombocytopenia

NCT02323178 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Prospective, One-arm and Open Clinical Study of Obinutuzumab in the Treatment of Immune Thrombocytopenia

NCT05995054 ·Status: RECRUITING ·Phase: PHASE2

Study to Evaluate Rilzabrutinib in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP)

NCT04562766 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Real-world Study of Herombopag in the Treatment of Thrombocytopenia Related Diseases in Henan Province

NCT05130424 ·Status: UNKNOWN

Safety and Treatment Satisfaction in Adults With Chronic ITP After Switching to Avatrombopag From Eltrombopag or Romiplostim

NCT04638829 ·Status: COMPLETED ·Phase: PHASE4

Safety and Efficacy Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Patients

NCT02614846 ·Status: UNKNOWN ·Phase: PHASE1

Efficacy and Safety of Romiplostim N01 Combined With Rituximab in Patients With Oral TPO-RA-Refractory Primary Immune Thrombocytopenia

NCT07206823 ·Status: RECRUITING ·Phase: NA